BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Kazia Therapeutics Advances First In Class Nuclear PD L1 Protein Degrader With Compelling Preclinical Evidence

Kazia Therapeutics (NASDAQ: KZIA), an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, announced co...

February 02, 2026 | News

SK Bioscience Launches Global Phase1/2 Trial In Australia For Universal Sarbecovirus Vaccine GBP511

SK bioscience announced the initiation of a global Phase 1/2 clinical trial in Australia for GBP511, a vaccine candidate targeting the sarbecovirus subgenu...

January 30, 2026 | News

Kazia Therapeutics Reports Encouraging Early Responses For Paxalisib Combination In Advanced Triple Negative Breast Cancer

Kazia Therapeutics provided a clinical update from its ongoing Phase 1b study evaluating paxalisib in combination with pembrolizumab and chemothe...

January 29, 2026 | News

Telix Doses First US Patient In Phase Three BiPASS Prostate Cancer Imaging Trial

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") announces that the first patient in the United States (U.S.) has been dosed in BiPASS&...

January 20, 2026 | News

Australia TGA Clears NMN As A Permissible Therapeutic Ingredient In Landmark Longevity Move

One of the most popular ingredients in the field of longevity science globally, nicotinamide mononucleotide (NMN) has officially been listed as...

January 15, 2026 | News

Clover Advances Global First In Class Respiratory Vaccine Strategy With Phase Two Launch

- Phase 2 Initiation Strengthens Global First-in-Class Potential for Clover's Protein-Based RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candid...

January 13, 2026 | News

Co Diagnostics Secures First Patent For Point Of Care PCR Platform In Australia

The Australian patent represents the first patent granted for the Company's new point-of-care testing platform Co-Diagnostics, I...

December 31, 2025 | News

Ferronova Raises $6 Million To Advance Nanoparticle Guided Cancer Surgery Technology

Australian company Ferronova has raised a further $6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solut...

December 18, 2025 | News

Atom Therapeutics Secures FDA Approval To Advance Phase II Trial Of ABP 745 In Atherosclerosis

Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, today announced FDA ...

December 18, 2025 | News

Pixelgen Expands Asia Pacific Footprint With South Korea Distribution Agreement

- Pixelgen Technologies, Inc. and MDxK (Molecular Diagnostics Korea) Inc., part of DKSH Business Unit Technology, a leader in market expansion se...

December 16, 2025 | News

ALL CONEC Signs MOU with Australia’s MINIMAX to Scale End-to-End Digital Implant Workflows

ALL CONEC has signed a memorandum of understanding (MOU) with Australian digital dental company MINIMAX to jointly promote digital implant production,...

December 15, 2025 | News

Telix Pharmaceuticals And Varian Enter Strategic Collaboration To Advance Precision Radiation Oncology

Telix Pharmaceuticals Limited announces a strategic clinical collaboration with Varian, a Siemens Healthineers company and global leader in radiation oncol...

December 12, 2025 | News

AdvanCell Launches Theraphase Two Expansion To Optimise Dosing For ADVC001 Across Key Prostate Cancer Settings

Clinical development of 212Pb-ADVC001 (ADVC001) is advancing rapidly with encouraging Phase 1b data presented at ESMO 2025 The Phase 2 expansion will ...

December 04, 2025 | News

Imugene and JW Therapeutics Launch First-in-Class “Mark and Kill” Solid Tumor Collaboration

Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlytic...

December 01, 2025 | News

Stay Connected